Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-037144
Date:2021-06-01
Issuer: PMV PHARMACEUTICALS, INC. (PMVP)
Original Submission Date:

Reporting Person:

HEYMAN RICHARD A.
C/O PMV PHARMACEUTICALS, INC.
8 CLARKE DRIVE, SUITE 3 CRANBURY, NJ 08512

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-06-01 M 1,950 a $2.95 1,950 indirect f1
COMMON STOCK 2021-06-01 S 1,392 d $32.15 558 indirect f1
COMMON STOCK 2021-06-01 S 553 d $33.61 5 indirect f1
COMMON STOCK 2021-06-01 S 5 d $34.67 0 indirect f1
COMMON STOCK 2021-06-01 M 975 a $2.95 975 indirect f5
COMMON STOCK 2021-06-01 S 743 d $32.16 232 indirect f5
COMMON STOCK 2021-06-01 S 230 d $33.75 2 indirect f5
COMMON STOCK 2021-06-01 S 2 d $34.67 0 indirect f5
COMMON STOCK 2021-06-01 M 975 a $975.00 975 indirect f8
COMMON STOCK 2021-06-01 S 764 d $32.15 211 indirect f8
COMMON STOCK 2021-06-01 S 209 d $33.79 2 indirect f8
COMMON STOCK 2021-06-01 S 2 d $34.67 0 indirect f8
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 2.95 2021-06-01 deemed execution date M 1,950 (d) 2027-08-16 common stock 1,950 $2.95 15,901 indirect see footnote
STOCK OPTION (RIGHT TO BUY) 2.95 2021-06-01 deemed execution date M 975 (d) 2027-08-16 common stock 975 $2.95 7,951 indirect see footnote
STOCK OPTION (RIGHT TO BUY) 2.95 2021-06-01 deemed execution date M 975 (d) 2027-08-16 common stock 975 $2.95 7,951 indirect see footnote
STOCK OPTION (RIGHT TO BUY) 2.95 2021-06-01 deemed execution date 0 ( ) 2027-08-16 common stock 11,901 $2.95 11,901 direct
Footnotes
IDfootnote
f1 the shares are held of record by paul l. vogel as trustee of the heyman family 2020 irrevocable trust under agreement dated august 31, 2020 for the benefit of the reporting person's immediate family.
f2 the sale reported in this form 4 was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on december 30, 2020.
f3 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $32.01 to $32.815, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (6), (7), (9) and (10) to this form 4.
f4 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $33.055 to $33.875, inclusive.
f5 the shares are held of record by paul l. vogel as trustee of the julia e. heyman 2016 irrevocable trust under agreement dated november 1, 2016 for the benefit of the reporting person's daughter and descendants.
f6 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $32.02 to $32.46, inclusive.
f7 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $33.62 to $33.875, inclusive.
f8 the shares are held of record by paul l. vogel as trustee of the scott z. heyman 2016 irrevocable trust under agreement dated november 1, 2016 for the benefit of the reporting person's son and descendants.
f9 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $32.00 to $32.815, inclusive.
f10 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $33.62 to $33.875, inclusive.
f11 all of the shares subject to the option are vested and immediately exercisable.
f12 the shares subject to the option are subject to an early exercise provision and are immediately exercisable. one forty-eighth of the shares subject to the option vested on september 17, 2017, and an additional one forty-eighth of the shares subject to the option shall vest each month thereafter.

Elevate your investments